drugset / Trial / NCT06014424
Cannabidiol Medication Intervention Trial
RandomizedCrossoverTriple-blindTreatment
Summary
CALM-IT is a Randomized, double-blind, placebo-controlled cross-over clinical trial. Safety and efficacy of cannabidiol (CBD) capsules assessed for managing agitation in patients with AD and to identify novel biomarkers of agitation severity and treatment response.
Timeline
- Start
- 2023-09-27
- Primary completion
- 2026-12-29
- Completion
- 2026-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 800 mg | — |